Indonesian Political, Business & Finance News

Government and Takeda Forge USD30 Million Strategic Partnership for Plasma Ecosystem

| | Source: industry.co.id Translated from Indonesian | Business
Government and Takeda Forge USD30 Million Strategic Partnership for Plasma Ecosystem
Image: industry.co.id

Takeda, together with the Indonesian government, has strengthened a strategic collaboration to build a national plasma industry ecosystem while expanding public access to Plasma-Derived Medicinal Products (PODP) — plasma-based medicines used in the treatment of various serious diseases.

The partnership involves the Ministry of Health, the Ministry of Investment and Downstream Industry/BKPM, and the Coordinating Ministry for Economic Affairs, as part of efforts to strengthen national health resilience and drive the development of the biopharmaceutical industry in Indonesia.

Under this cooperation, the Ministry of Health has designated Takeda as a pharmaceutical company authorised to carry out plasma fractionation for the production of PODP.

This designation marks the first step for the company to develop a plasma collection system and carry out the fractionation process in stages, with a view to building a plasma industry ecosystem in Indonesia.

The collaboration also represents an important milestone in the government’s strategy to strengthen self-reliance in the health sector through the development of high-technology-based industry.

“This initiative reflects the Indonesian government’s commitment to building a strategic industry in the health sector and ensuring that the public has better access to essential and innovative treatments,” said Minister of Health of the Republic of Indonesia, Budi Gunadi Sadikin.

Minister Budi added: “Through this partnership with Takeda, we hope to strengthen the national health system whilst preparing Indonesia to face future health challenges.”

The programme, prepared as a long-term initiative, is described as the first of its kind in Southeast Asia. It focuses on building a sustainable, high-quality plasma collection system whilst supporting large-scale PODP manufacturing.

With its long experience in Indonesia, Takeda is optimistic it can contribute to the development of plasma science, plasma collection technology, and biopharmaceutical manufacturing and innovation.

The company believes the move could open opportunities for Indonesia to develop into one of the region’s plasma industry hubs.

“This partnership demonstrates Takeda’s commitment to expanding access to PODP whilst supporting the development of a sustainable plasma ecosystem in Indonesia,” said Ramy Riad, President of Plasma-Derived Therapies at Takeda.

Takeda also reaffirmed its commitment to building plasma industry infrastructure from upstream to downstream, whilst expanding cooperation with the Indonesian government.

“We hope Takeda’s global experience can support Indonesia’s long-term goals of improving health services, creating highly skilled jobs, and strengthening the availability of life-saving and life-sustaining services and treatments for patients,” Ramy Riad added.

As a first step in implementation, Takeda will invest up to USD30 million, or around IDR539 billion, over the next two years to build a number of plasma banks in Indonesia.

The results of this first phase of development will later be evaluated together with the Ministry of Health before being expanded into a national plasma bank network.

All plasma banks built will adopt Takeda’s global experience in plasma donor management by applying international quality and regulatory standards.

In addition to strengthening the national plasma supply, the project is expected to create new jobs for health workers and laboratory technicians, whilst enhancing human resource capacity through training and knowledge transfer.

Separately, Takeda will also study the opportunity to build a high-technology PODP manufacturing facility in Indonesia.

The presence of such a facility is expected to meet domestic needs whilst opening export opportunities to global markets, thereby strengthening Indonesia’s position in the global health industry supply chain.

Minister of Investment and Downstream Industry/Head of BKPM, Rosan P. Roeslani, expressed a similar view. He considers the investment to be of strategic value because it not only brings in new capital but also opens opportunities for technology transfer, the development of national human resources, and job creation.

“This partnership not only strengthens Indonesia’s health ecosystem but also supports our vision of making Indonesia a regional hub for health innovation and advanced pharmaceutical manufacturing,” said Rosan.

Amid rising global demand for PODP, many countries in Southeast Asia, including Indonesia, still face challenges in ensuring its availability.

This situation is compounded by low diagnosis rates and the still limited understanding of diseases that can be treated through plasma-based therapies.

Through this partnership, Takeda and the Indonesian government aim to create a more reliable supply of plasma and PODP for domestic patients.

These efforts are also expected to strengthen the global plasma industry ecosystem through the development of local capabilities, increased public awareness, investment in health workers, and the application of best practices in plasma collection and processing.

The first plasma bank is targeted to begin operating in 2027 and will form part of Takeda’s BioLife network.

Meanwhile, while the plasma fractionation facility in Indonesia is still under study, the plasma collected will be processed through Takeda’s global manufacturing network, with priority given to meeting Indonesia’s PODP needs in accordance with applicable laws and regulations.

More from 13 July 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/government-and-takeda-forge-usd30-million-strategic-partnership-for-plasma-ecosystem-1783918216)
Originally published by industry.co.id (https://www.industry.co.id/amp/read/153038/pemerintah-dan-takeda-jalin-kemitraan-strategis-ekosistem-plasma-senilai-usd30-juta), translated from Indonesian
Print